"Routine" weekly blood counts during breast irradiation for early stage cancer: Are they really necessary?

Breast Journal

Volumn 7, Issue 6, 2001, Pages 450-452

  Ampil, Federico L ^a   Burton, Gary V ^a   Li, Benjamin D L ^b  

^a Louisiana State University Health Sciences Center at Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Breast conservation surgery; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ANEMIA; ARTICLE; BLOOD CELL COUNT; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURGERY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; POPULATION RISK; RADIATION HAZARD; THROMBOCYTOPENIA;

ADULT; BLOOD CELL COUNT; BREAST NEOPLASMS; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MIDDLE AGED; RADIOTHERAPY, ADJUVANT;

EID: 0035667382     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2001.07615.x     Document Type: Article

References (9)

1. The utility of serial complete blood count monitoring in patients receiving radiation therapy for localized prostate cancer
2. Is it necessary to check blood counts routinely during definitive radiation therapy for patients with early stage breast cancer?
3. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy
4. Radiotherapy with or without chemotherapy after breast conservation surgery for early stage breast cancer: A review of timing
5. Overview
6. 60 teletherapy) on the peripheral blood and bone marrow
7. Circulating stem cells: Variation with duration of partial body x-irradiation
8. Local bone-marrow changes secondary to therapeutic irradiation
9. The distribution of active bone marrow in the adult